Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Dec;2(4):297-312.
doi: 10.1007/s11481-007-9071-5. Epub 2007 Apr 3.

Toll-like receptors in defense and damage of the central nervous system

Affiliations
Review

Toll-like receptors in defense and damage of the central nervous system

Rajagopal N Aravalli et al. J Neuroimmune Pharmacol. 2007 Dec.

Abstract

Members of the Toll-like receptor (TLR) family play critical roles as regulators of innate and adaptive immune responses. TLRs function by recognizing diverse molecular patterns on the surface of invading pathogens. In the brain, microglial cells generate neuroimmune responses through production of proinflammatory mediators. The upregulation of cytokines and chemokines in response to microbial products and other stimuli has both beneficial and deleterious effects. Emerging evidence demonstrates a central role for TLRs expressed on microglia as a pivotal factor in generating these neuroimmune responses. Therefore, understanding the basis of TLR signaling in producing these responses may provide insights into how activated microglia attempt to strike a balance between defense against invading pathogens and inflicting irreparable brain damage. These insights may lead to innovative therapies for CNS infections and neuroinflammatory diseases based on the modulation of microglial cell activation through TLR signaling.

PubMed Disclaimer

References

    1. Nature. 2004 Mar 18;428(6980):341-5 - PubMed
    1. Microbes Infect. 2004 Nov;6(14):1268-72 - PubMed
    1. Infect Immun. 2004 Feb;72(2):1204-9 - PubMed
    1. Curr Drug Targets Inflamm Allergy. 2002 Jun;1(2):181-91 - PubMed
    1. J Neurovirol. 2006 Dec;12(6):501-10 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources